It appears an inexpensive hypothesis that the negative effects these long significant cannabis users rumored are because of being acutely intoxicated each day. Cannabis users who answer a billboard for a study might not be representative of the supply population from that they're drawn. Although CB1 receptors are present in extremely high concentrations throughout the brain, they're most dense within the hippocampus, basal ganglia and cerebellum. If this hypothesis were true, one would expect the long-term cannabis users to deny the adverse effects of cannabis use. The potential of glia and cannabinoid receptors in glia merits special attention in PD but also in AD (see below). Cannabis users may suspect that they might be rejected from the study, and not get the associated compensation if they rumored vital use of alternative medicine or psychiatric disorders. A splice variant of the CB1 receptor, CB1A, has also been described. Maybe regulated by ligands acting at the cannabinoid receptors have been detected in the vessels from a transgenic AD model. Additionally, mRNA coding for the CB2 receptor has been detected in cerebellar granule cells. However, the amount of faculty graduation among themselves was dramatically different, with fewer than half the heavy cannabis users having obtained a school degree as hostile almost 80% of the control subjects. The parental education in each team was virtually the same, with 58% of the significant cannabis users and 51% of the managements having a minimum of one parent who graduated from college. Apart from the difficulty in assessing neuroprotection in humans, it turns out that transgenic Alzheimer’s disease models do not display neuronal death. CB1 Receptor a. CB2 Receptor a. The presence of undiscovered cannabinoid receptors isn't only limited to the CNS.